{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Dunja Przulj, Francesca Pesola, Katie Myers Smith, Hayden McRobbie, Tim Coleman, Sarah Lewis, Christopher Griffith, Robert Walton, Rachel Whitemore, Miranda Clark, Michael Ussher, Lesley Sinclair, Emily Seager, Sue Cooper, Linda Bauld, Felix Naughton, Peter Sasieni, Isaac Manyonda & Peter Hajek.

Dunja Przulj ¹, Francesca Pesola ¹, Katie Myers Smith ^1,*, Hayden McRobbie ², Tim Coleman ³, Sarah Lewis ³, Christopher Griffith ¹, Robert Walton ¹, Rachel Whitemore ³, Miranda Clark ³, Michael Ussher ⁴, Lesley Sinclair ⁵, Emily Seager ¹, Sue Cooper ³, Linda Bauld ⁵, Felix Naughton ⁶, Peter Sasieni ⁷, Isaac Manyonda ⁸, Peter Hajek ¹

¹ Wolfson Institute of Population Health, Queen Mary University of London, London, UK
² National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
³ School of Medicine, University of Nottingham, Nottingham, UK
⁴ Population Health Research Institute, St George’s University of London, London, UK
⁵ Usher Institute and SPECTRUM Consortium, Centre for Population Health Sciences, Old Medical School, Edinburgh, UK
⁶ School of Health Sciences, University of East Anglia, Norwich, UK
⁷ The Cancer Research UK and King’s College London Cancer Prevention Trials Unit, King’s College London, Institute of Psychiatry, London, UK
⁸ St George’s University Hospital NHS Foundation Trust, London, UK
^* Corresponding author Email: katie.smith@qmul.ac.uk

Disclosure of interests of authors

Full disclosure of interests: Completed ICMJE forms for all authors, including all related interests, are available in the toolkit on the NIHR Journals Library report publication page at https://doi.org/10.3310/AGTH6901.

Primary conflicts of interest: Linda Bauld is on the Public Health Research (PHR) Research Funding Board. Peter Hajek received research funding from and provided consultancy to Pfizer Inc. (New York, NY, USA). Hayden McRobbie received honoraria for speaking at smoking cessation meetings and attending advisory board meetings that have been organised by Pfizer Inc. Felix Naughton received consultancy fees from ResMed for a project that he led, designing an app that provided smoking behaviour change advice and connected to a novel inhaled nicotine replacement therapy device, although the company did not/does not make the nicotine device. Peter Sasieni is an unpaid chair of a Trial Steering Committee for Yorkshire Cancer Research (YESS) and holds Cancer Research UK grants and National Institute for Health and Care Research (NIHR) Clinical Trials Unit Support Funding. Lesley Sinclair was awarded funding for the Cessation in Pregnancy Incentives Trial (CPIT).